Recombinant Veterinary Vaccines

Current Developments in Biotechnology and Bioengineering: Human and Animal Health Applications

Volumn , Issue , 2017, Pages 439-458

  Dellagostin, O A ^a   Felix, S R ^a   Jorge, S ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Animal vaccines; Immunization; Recombinant DNA technology; Reverse vaccinology; Vaccine technology; Veterinary medicine; Veterinary vaccines

Indexed keywords

ANIMALS; COST EFFECTIVENESS; DISEASE CONTROL; GENETIC ENGINEERING; IMMUNIZATION; VETERINARY MEDICINE;

CONVENTIONAL METHODS; EXPRESSION SYSTEM; FUTURE PERSPECTIVES; PROTECTIVE ANTIGENS; RECOMBINANT VACCINES; REVERSE VACCINOLOGY; VACCINE TECHNOLOGIES; VETERINARY VACCINES;

VACCINES;

EID: 85012157725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-63660-7.00017-6     Document Type: Chapter

References (58)

1. Adler B., de la Peña Moctezuma A. Leptospira and leptospirosis. Veterinary Microbiology 2010, 140(3-4):287-296.
2. Andreotti R. Performance of two Bm86 antigen vaccine formulation against tick using crossbreed bovines in stall test. Brazilian Journal of Veterinary Parasitology 2006, 15(3):97-100.
3. Bacelo K.L., Hartwig D.D., Seixas F.K., Schuch R., Moreira A., da S., Amaral M., Collares T., Vendrusculo C.T., Mcbride A.J.A., Dellagostin O.A. Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis. BioMed Research International 2014, 2014:1-10.
4. Bassetto C.C., Amarante A.F.T. Vaccination of sheep and cattle against haemonchosis. Journal of Helminthology 2015, 89(5):5171-5525.
5. Blanco J.L., Garcia M.E. Immune response to fungal infections. Veterinary Immunology and Immunopathology 2008, 125(1-2):47-70.
6. Bruno L., Cortese M., Rappuoli R., Merola M. Lessons from reverse vaccinology for viral vaccine design. Current Opinion in Virology 2015, 11:89-97.
7. Cerqueira G.M., Picardeau M. A century of Leptospira strain typing. Infection, Genetics and Evolution 2009, 9(5):760-768.
8. Coutinho M.L., Choy H.A., Kelley M.M., Matsunaga J., Babbitt J.T., Lewis M.S., Aleixo J.A.G., Haake D.A. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Neglected Tropical Diseases 2011, 5(12):1-10.
9. Da Costa C., Walker B., Bonavia A. Tuberculosis Vaccines - state of the art, and novel approaches to vaccine development. International Journal of Infectious Diseases 2015, 32:5-12.
10. Dawson A., Harvey R.E., Thevasagayam S.J., Sherington J., Peters A.R. Studies of the field efficacy and safety of a single-dose Mycoplasma hyopneumoniae vaccine for pigs. The Veterinary record 2002, 151(18):535-538.
11. Delany I., Rappuoli R., De Gregorio E. Vaccines for the 21st century. EMBO Molecular Medicine 2014, 6(6):708-720.
12. Dellagostin O.A., Grassmann A.A., Hartwig D.D., Félix S.R., da Silva É F., Mcbride A.J.A. Recombinant vaccines against leptospirosis. Human Vaccines 2011, 7(11):1215-1224.
13. Dunham S.P. The application of nucleic acid vaccines in veterinary medicine. Research in Veterinary Science 2002, 73(1):9-16.
14. Ellis J.A. How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014. The Veterinary Journal 2015, 204(1):5-16.
15. Eshghi A., Cullen P.A., Cowen L., Zuerner R.L., Cameron C.E. Global proteome analysis of Leptospira interrogans. Journal of Proteome Research 2009, 8(10):4564-4578.
16. Ferraz Coelho E.A., Pereira Tavares C.A., Amorim Carvalho F.A., Chaves K.F., Teixeira K.N., Rodrigues R.C., Charest H., Matlashewski G., Gazzinelli R.T., Fernandes A.P. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infection and Immunity 2003, 71(7):3988-3994.
17. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., Bult C.J., Tomb J.F., Dougherty B.A., Merrick J.M. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 1995, 269(5223):496-512.
18. Galli V., Simionatto S., Marchioro S.B., Fisch A., Gomes C.K., Conceição F.R., Dellagostin O.A. Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines. Vaccine 2012, 31(1):135-140.
19. Galli V., Simionatto S., Marchioro S.B., Klabunde G.H.F., Conceição F.R., Dellagostin O.A. Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice. Clinical and Vaccine Immunology 2013, 20(9):1370-1376.
20. Ghosh S., Nagar G. Problem of ticks and tick-borne diseases in India with special emphasis on progress in tick control research: a review. Journal of Vector Borne Diseases 2014, 51(4):259-270.
21. Hartwig D.D., Oliveira T.L., Seixas F.K., Forster K.M., Rizzi C., Hartleben C.P., Mcbride A.J.A., Dellagostin O.A. High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microbial Cell Factories 2010, 9(1):98.
22. Hartwig D.D., Forster K.M., Oliveira T.L., Amaral M., mcbride A.J.A., Dellagostina O.A. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clinical and Vaccine Immunology 2013, 20(5):747-752.
23. Hein W.R., Harrison G.B.L. Vaccines against veterinary helminths. Veterinary Parasitology 2005, 132(3-4):217-222.
24. Heinson A.I., Woelk C.H., Newell M. The promise of reverse vaccinology. International Health 2015, 7(2):85-89.
25. Hoebe K., Janssen E., Beutler B. The interface between innate and adaptive immunity. Nature Immunology 2004, 5(10):971-974.
26. Jorge S., de Oliveira N.R., Marchioro S.B., Fisch A., Gomes C.K., Hartleben C.P., Conceição F.R., Dellagostin O.A. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions. Comparative Immunology, Microbiology and Infectious Diseases 2014, 37(4):229-236.
27. Larrieu E., Herrero E., Mujica G., Labanchi J.L., Araya D., Grizmado C., Calabro A., Talmon G., Ruesta G., Perez A., Gatti A., Santillán G., Cabrera M., Arezzo M., Seleiman M., Cavagión L., Cachau M.G., Alvarez Rojas C.A., Gino L., et al. Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary data. Acta Tropica 2013, 127(2):143-151.
28. Levett P.N. Leptospirosis. Clinical Microbiology 2001, 14(2):296-326.
29. Lightowlers M.W. Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. Parasitology 2013, 140(13):1566-1577.
30. Marchioro S.B., Maes D., Flahou B., Pasmans F., Del Pozo Sacristán R., Vranckx K., Melkebeek V., Cox E., Wuyts N., Haesebrouck F. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine. Vaccine 2013, 31(9):1305-1311.
31. Marchioro S.B., Sácristan R.D.P., Michiels A., Haesebrouck F., Conceição F.R., Dellagostin O.A., Maes D. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs. Vaccine 2014, 32(36):4689-4694.
32. Mašek J., Bartheldyová E., Turánek-Knotigová P., Škrabalová M., Korvasová Z., Plocková J., Koudelka Š., Škodová P., Kulich P., Kupka M., Zachová K., Czerneková L., Horynová M., Kratochvílová I., Miller A.D., Zỳka D., Michálek J., Vrbková J., Šebela M., et al. Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant His-tagged antigens: preparation, structural study and immune response towards rHsp90. Journal of Controlled Release 2011, 151(2):193-201.
33. Mcallister M.M. Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs. Parasitology 2014, 141(5):624-640.
34. Mcvey S., Shi J. Vaccines in veterinary medicine: a brief review of history and technology. Veterinary Clinics of North America - Small Animal Practice 2010, 40(3):381-392.
35. Molina-Hernández V., Mulcahy G., Pérez J., Martínez-Moreno á., Donnelly S., O'neill S.M., Dalton J.P., Cwiklinski K. Fasciola hepatica vaccine: we may not be there yet but we're on the right road. Veterinary Parasitology 2015, 208(1-2):101-111.
36. Nisbet A.J., Huntley J.F. Progress and opportunities in the development of vaccines against mites, fleas and myiasis-causing flies of veterinary importance. Parasite Immunology 2006, 28(4):165-172.
37. Nisbet A.J., Mackellar A., Wright H.W., Brennan G.P., Chua K.Y., Cheong N., Thomas J.E., Huntley J.F. Molecular characterization, expression and localization of tropomyosin and paramyosin immunodominant allergens from sheep scab mites (Psoroptes ovis). Parasitology 2006, 133(4):515-523.
38. Petavy A.-F., Hormaeche C., Lahmar S., Ouhelli H., Chabalgoity A., Marchal T., Azzouz S., Schreiber F., Alvite G., Sarciron M.-E., Maskell D., Esteves A., Bosquet G. An oral recombinant vaccine in dogs against Echinococcus granulosus, the causative agent of human hydatid disease: a pilot study. PLoS Neglected Tropical Diseases 2008, 2(1):E125.
39. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Aricò B., Comanducci M., Jennings G.T., Baldi L., Bartolini E., Capecchi B., Galeotti C.L., Luzzi E., Manetti R., Marchetti E., Mora M., Nuti S., Ratti G., Santini L., Savino S., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287(5459):1816-1820.
40. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 2001, 19(17-19):2688-2691.
41. Redding L., Weiner D.B. DNA vaccines in veterinary use. Expert Review of Vaccines 2009, 8(9):1251-1276.
42. Rizzi C., Bianco M.V., Blanco F.C., Soria M., Gravisaco M.J., Montenegro V., Vagnoni L., Buddle B., Garbaccio S., Delgado F., Leal K.S., Cataldi A.A., Dellagostin O.A., Bigi F. Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge. PloS One 2012, 7(12):E51396.
43. Roberts B., Antonopoulos A., Haslam S.M., Dicker A.J., Mcneilly T.N., Johnston S.L., Dell A., Knox D.P., Britton C. Novel expression of Haemonchus contortus vaccine candidate aminopeptidase H11 using the free-living nematode Caenorhabditis elegans. Veterinary Research 2013, 44(1):1-15.
44. Seixas F.K., da Silva É F., Hartwig D.D., Cerqueira G.M., Amaral M., Fagundes M.Q., Dossa R.G., Dellagostin O.A. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 2007, 26(1):88-95.
45. Sibila M., Pieters M., Molitor T., Maes D. Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection. The Veterinary Journal 2009, 181(3):221-231.
46. Silva É F., Brod C.S., Cerqueira G.M., Bourscheidt D., Seyffert N., Queiroz A., Santos C.S., Ko A.I., Dellagostin O.A. Isolation of Leptospira noguchii from sheep. Veterinary Microbiology 2007, 121(1-2):144-149.
47. Silva É F., Medeiros M.A., Mcbride A.J.A., Matsunaga J., Esteves G.S., Ramos J.G.R., Santos C.S., Croda J., Homma A., Dellagostin O.A., Haake D.A., Reis M.G., Ko A.I. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007, 25(33):6277-6286.
48. Silver G.M., Gaines P.J., Hunter S.W., Maddux J.D., Thomas R.E., Wisnewski N. Identification, characterization, and cloning of an immunoglobulin degrading enzyme in the cat flea, Ctenocephalides felis. Archives of Insect Biochemistry and Physiology 2002, 51(3):136-150.
49. Simionatto S., Marchioro S.B., Galli V., Hartwig D.D., Carlessi R.M., Munari F.M., Laurino J.P., Conceicao F.R., Dellagostin O.A. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli. Protein Expression and Purification 2010, 69(2):132-136.
50. Simionatto S., Beutinger S., Maes D. Mycoplasma hyopneumoniae: from disease to vaccine development. Veterinary Microbiology 2013, 165(3-4):234-242.
51. Singh M., O'Hagan D.T. Recent advances in veterinary vaccine adjuvants. International Journal for Parasitology 2003, 33(5-6):469-478.
52. Takeda K., Akira S. Roles of Toll-like receptors in innate immune responses. Genes to Cells: Devoted to Molecular & Cellular Mechanisms 2001, 6(9):733-742.
53. Tettelin H., Saunders N.J., Heidelberg J., Jeffries A.C., Nelson K.E., Eisen J.A., Ketchum K.A., Hood D.W., Peden J.F., Dodson R.J., Nelson W.C., Gwinn M.L., Deboy R., Peterson J.D., Hickey E.K., Haft D.H., Salzberg S.L., White O., Fleischmann R.D., et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 2000, 287(5459):1809-1815.
54. Tripp R.A., Tompkins S.M. Virus-vectored influenza virus vaccines. Viruses 2014, 3055-3079.
55. Unnikrishnan M., Rappuoli R., Serruto D. Recombinant bacterial vaccines. Current Opinion in Immunology 2012, 24(3):337-342.
56. Vasconcelos A.T.R., Ferreira H.B., Bizarro C.V., Bonatto S.L., Carvalho M.O., Pinto P.M., Almeida D.F., Almeida L.G.P., Almeida R., Alves-filho L., Assunc E.N., Bogo R., Brigido M.M., Brocchi M., Burity H.A., Camargo A.A., Camargo S.S., Carepo M.S., Carraro D.M., et al. Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. Journal of Bacteriology 2005, 187(16):5568-5577.
57. Weighardt H., Jusek G., Mages J., Lang R., Hoebe K., Beutler B., Holzmann B. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. European Journal of Immunology 2004, 34(2):558-564.
58. Willadsen P. Anti-tick vaccines. Parasitology 2004, 129(Suppl.):S367-S387.